(Q34003152)

30 July 2017

1 reference

title

Gene therapy approaches for modulating bone regeneration (English)

1 reference

30 July 2017

0 references

Winn SR

1

1 reference

30 July 2017

Hu Y

series ordinal

2

1 reference

30 July 2017

Sfeir C

series ordinal

3

1 reference

30 July 2017

Hollinger JO

series ordinal

4

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 August 2000

1 reference

Advanced Drug Delivery Reviews

30 July 2017

published in

1 reference

30 July 2017

volume

42

1 reference

30 July 2017

issue

1-2

1 reference

30 July 2017

page(s)

121-138

1 reference

Evolution of bone transplantation: molecular, cellular and tissue strategies to engineer human bone

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

New challenges in biomaterials

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Role of bone substitutes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Poly(alpha-hydroxy acids): carriers for bone morphogenetic proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Sustained release emphasizing recombinant human bone morphogenetic protein-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Gene therapy for tissue repair and regeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Mesenchymal stem cells in bone development, bone repair, and skeletal regeneration therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Stimulation of new bone formation by direct transfer of osteogenic plasmid genes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Bone regeneration by implantation of purified, culture-expanded human mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Regional gene therapy with a BMP-2-producing murine stromal cell line induces heterotopic and orthotopic bone formation in rodents

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Localized, direct plasmid gene delivery in vivo: prolonged therapy results in reproducible tissue regeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Tissue-engineered bone biomimetic to regenerate calvarial critical-sized defects in athymic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Carrier systems for bone morphogenetic proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Bone morphogenetic protein

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Expression of an exogenous growth hormone gene by transplantable human epidermal cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Efficient retrovirus-mediated transfer and expression of a human adenosine deaminase gene in diploid skin fibroblasts from an adenosine deaminase-deficient human

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Clonal gene therapy: transplanted mouse fibroblast clones express human alpha 1-antitrypsin gene in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Grafting genetically modified cells to the damaged brain: restorative effects of NGF expression

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Implantation of vascular grafts lined with genetically modified endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Systemic delivery of recombinant proteins by genetically modified myoblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Gene therapy via primary myoblasts: long-term expression of factor IX protein following transplantation in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

In utero hematopoietic stem cell transfer: current status and future strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Naked DNA transport and expression in mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Nonviral strategies for gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Chapter 27 Particle Bombardment

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Particle-mediated nucleic acid immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Biologically erodable microspheres as potential oral drug delivery systems

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Biomedical applications of nanotechnology--implications for drug targeting and gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Transfer of genes to humans: early lessons and obstacles to success

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Endogenous mouse leukemia viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Xenotropic viruses: murine leukemia viruses associated with NIH Swiss, NZB, and other mouse strains.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Development of HIV vectors for anti-HIV gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Productive human immunodeficiency virus type 1 (HIV-1) infection of nonproliferating human monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Lentivirus-mediated transduction of islet grafts with interleukin 4 results in sustained gene expression and protection from insulitis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

In vivo expression of full-length human dystrophin from adenoviral vectors deleted of all viral genes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

A helper-dependent adenovirus vector system: removal of helper virus by Cre-mediated excision of the viral packaging signal

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

The presence of human coxsackievirus and adenovirus receptor is associated with efficient adenovirus-mediated transgene expression in human melanoma cell cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Integrin alpha v beta 5 selectively promotes adenovirus mediated cell membrane permeabilization.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Researchers and regulators reflect on first gene therapy death

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Optimization of packaging of adeno-associated virus gene therapy vectors using plasmid transfections

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Gene therapy: basic concepts and recent advances

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Viral vectors, tools for gene transfer in the nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Cationic liposomes for direct gene transfer in therapy of cancer and other diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Immunostimulatory DNA sequences necessary for effective intradermal gene immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Enhancement of fracture-healing.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

The integrated processes of hard tissue regeneration with special emphasis on fracture healing

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Growth factor regulation of fracture repair.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

1 reference

7 January 2021

Potential role of insulinlike growth factors in fracture healing

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Gene expression of insulin-like growth factors I and II in rat membranous osteotomy healing.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Transforming growth factor beta in fracture repair

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

The potential role of transforming growth factor beta in fracture healing

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Single local injection of recombinant fibroblast growth factor-2 stimulates healing of segmental bone defects in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Recombinant human basic fibroblast growth factor accelerates fracture healing by enhancing callus remodeling in experimental dog tibial fracture

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Systemic administration of acidic fibroblast growth factor (FGF-1) prevents bone loss and increases new bone formation in ovariectomized rats

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

The biology of vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Vascular endothelial growth factor and microvascular permeability

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Expression of bone morphogenetic proteins in fracture healing

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Distinct and overlapping patterns of localization of bone morphogenetic protein (BMP) family members and a BMP type II receptor during fracture healing in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

The bone morphogenetic protein family: multifunctional cellular regulators in the embryo and adult

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Cytokines and growth factors in the regulation of bone remodeling

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Porous hydroxyapatite as a bone graft substitute in alveolar ridge augmentation: a histometric study.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Regulation of cartilage and bone differentiation by bone morphogenetic proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Use of polyphosphazenes for skeletal tissue regeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Comparison of canine and non-human primate animal models for periodontal regenerative therapy: results following a single administration of PDGF/IGF-I

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Use of demineralized bone implants in orbital and craniofacial reconstruction and a review of the literature.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Bone morphogenetic protein: the molecularization of skeletal system development

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Reconstruction of bone using calcium phosphate bone cements: a critical review

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Purification and characterization of other distinct bone-inducing factors

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Osteogenic activity of OP-1 bone morphogenetic protein (BMP-7) in a human fibular defect

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Characterization of rhBMP-2 pharmacokinetics implanted with biomaterial carriers in the rat ectopic model

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

rhBMP-collagen sponges as osteoinductive devices: effects of in vitro sponge characteristics and protein pI on in vivo rhBMP pharmacokinetics

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

The effects of short-term application of a combination of platelet-derived and insulin-like growth factors on periodontal wound healing

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Periodontal tissue engineering by growth factors.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

1 reference

7 January 2021

Putting stem cells to work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

The effect of implants loaded with autologous mesenchymal stem cells on the healing of canine segmental bone defects

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Establishing an immortalized human osteoprecursor cell line: OPC1.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Tissue engineering of bone in the craniofacial complex

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Bone progenitor cell deficits and the age-associated decline in bone repair capacity

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

DNA delivery from polymer matrices for tissue engineering

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Cancer Gene Therapy Using Plasmid DNA: Pharmacokinetic Study of DNA Following Injection in Mice

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Cancer Gene Therapy Using Plasmid DNA: Purification of DNA for Human Clinical Trials

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Cancer Gene Therapy Using Plasmid DNA: Safety Evaluation in Rodents and Non-Human Primates

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Safety of in vivo adenovirus-mediated thymidine kinase treatment of oral cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Optimizing suicide gene therapy for head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Gene therapy for oral cancer: recent progress in research

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Evidence for the systemic delivery of a transgene product from salivary glands

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Retrovirus-mediated gene transfer into salivary glands in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Cementum specific components which influence periodontal connective tissue cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Isolation of human tumor cells that produce cementum proteins in culture

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Production of a monoclonal antibody to an attachment protein derived from human cementum

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Development of the murine periodontium. I. Role of basement membrane in formation of a mineralized tissue on the developing root dentin surface

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Hertwig's epithelial root sheath differentiation and initial cementum and bone formation during long-term organ culture of mouse mandibular first molars using serumless, chemically-defined medium

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Induction of dentin formation on canine amputated pulp by recombinant human bone morphogenetic proteins (BMP)-2 and -4.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

A new biological approach to vital pulp therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Transdentinal stimulation of reparative dentine formation by osteogenic protein-1 in monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Human parathyroid hormone-(1-34) prevents bone loss and augments bone formation in sexually mature ovariectomized rats

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Effects of combined and separate intermittent administration of low-dose human parathyroid hormone fragment (1-34) and 17 beta-estradiol on bone histomorphometry in ovariectomized rats with established osteopenia

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Loss of cancellous bone mass and connectivity in ovariectomized rats can be restored by combined treatment with parathyroid hormone and estradiol

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

The effect on vertebral bone mass and strength of long term treatment with antiresorptive agents (estrogen and calcitonin), human parathyroid hormone-(1-38), and combination therapy, assessed in aged ovariectomized rats

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

The BMP proteins in bone formation and repair

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Bone morphogenetic proteins (BMPs): therapeutic potential in healing bony defects

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

What do BMPs do in mammals? Clues from the mouse short-ear mutation

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Maxillary alveolar cleft repair in dogs using recombinant human bone morphogenetic protein-2 and a polymer carrier

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Bone formation with use of rhBMP-2 (recombinant human bone morphogenetic protein-2)

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Bone morphogenetic protein-2 causes commitment and differentiation in C3H10T1/2 and 3T3 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Responsiveness of clonal limb bud cell lines to bone morphogenetic protein 2 reveals a sequential relationship between cartilage and bone cell phenotypes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Distribution and characterization of specific cellular binding proteins for bone morphogenetic protein-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Bone morphogenetic protein-2 but not bone morphogenetic protein-4 and -6 stimulates chemotactic migration of human osteoblasts, human marrow osteoblasts, and U2-OS cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Bone morphogenetic proteins: from basic studies to clinical approaches

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Bone morphogenetic proteins: an update on basic biology and clinical relevance

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Cloned 3T6 cell line from CD-1 mouse fetal molar dental papillae

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

Immortalized cementoblasts and periodontal ligament cells in culture

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900057-0

7 January 2021

10.1016/S0169-409X(00)00057-0

Identifiers

DOI

1 reference

30 July 2017

1 reference